Authors: Ligibel, J Seiden, M Spitzer, TR

Citation: J. Ligibel et al., Panel reactive antibodies in women with ovarian cancer undergoing high-dose chemotherapy with peripheral stem cell rescue: A case control study, J HEMATH ST, 9(4), 2000, pp. 501-505

Authors: Tung, N Berkowitz, R Matulonis, U Quartulli, M Seiden, M Kim, Y Niloff, J Cannistra, SA

Citation: N. Tung et al., Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer, GYNECOL ONC, 77(2), 2000, pp. 271-277

Authors: Cook, S Penson, R Duska, L Nikrui, N Goodman, A Fuller, A Seiden, M

Citation: S. Cook et al., Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer, GYNECOL ONC, 77(1), 2000, pp. 48-54

Authors: Smith, MR Kaufman, D Oh, W Guerin, K Seiden, M Makatsoris, T Manola, J Kantoff, PW

Citation: Mr. Smith et al., Vinorelbine and estramustine in androgen-independent metastatic prostate cancer - A phase II study, CANCER, 89(8), 2000, pp. 1824-1828